{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:16:10Z","timestamp":1791306970206,"version":"4.3.1"},"reference-count":231,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/14737175.2025.2605711","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:56:32Z","timestamp":1767884192000},"page":"279-300","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["An overview of the current management and emerging therapies of Multiple system atrophy"],"prefix":"10.1080","volume":"26","author":[{"given":"Cristiano","family":"Sorrentino","sequence":"first","affiliation":[{"name":"AOU San Giovanni di Dio e Ruggi d\u2019Aragona","place":["Salerno, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Baldelli","sequence":"additional","affiliation":[{"name":"Universit\u00e0 di Bologna","place":["Bologna, Italy"]},{"name":"UOC Clinica Neurologica NeuroMet","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Calandra-Buonaura","sequence":"additional","affiliation":[{"name":"Universit\u00e0 di Bologna","place":["Bologna, Italy"]},{"name":"UOC Clinica Neurologica NeuroMet","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Pellecchia","sequence":"additional","affiliation":[{"name":"AOU San Giovanni di Dio e Ruggi d\u2019Aragona","place":["Salerno, Italy"]},{"name":"University of Salerno","place":["Baronissi, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1311488"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-022-01411-6"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23192"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00890-x"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21992"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-140434"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.3.300"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.36.3.350"},{"key":"e_1_3_4_10_1","article-title":"Reduced maximal range of ocular movements and its response to acute levodopa challenge in Parkinson\u2019s disease","volume":"16","author":"Li J","year":"2024","unstructured":"Li J, Li Y, Chu X, et al. Reduced maximal range of ocular movements and its response to acute levodopa challenge in Parkinson\u2019s disease. Front Aging Neurosci [Internet]. 2024 [cited 2025 Sep 28];16:1\u201310.","journal-title":"Front Aging Neurosci"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14100991"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870010203"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.2.160"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2021.04.008"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/117.4.835"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.11.1009"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29005"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.44.4.347"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01250796"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1984.04050150049015"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.08.909"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70288-1"},{"issue":"1","key":"e_1_3_4_23_1","article-title":"May safinamide have a role in atypical parkinsonism? A retrospective study in clinical practice","volume":"35","author":"Rodr\u00edguez Jorge F","year":"2020","unstructured":"Rodr\u00edguez Jorge F, Beltr\u00e1n Corbellini A, Chico Garc\u00eda JL, et al. May safinamide have a role in atypical parkinsonism? A retrospective study in clinical practice. Mov Disord. 2020;35(suppl 1):[abstract].","journal-title":"Mov Disord"},{"issue":"2","key":"e_1_3_4_24_1","article-title":"Is safinamide useful for atypical parkinsonian syndromes?","volume":"33","author":"Mach\u00edo Castell\u00f3 M","year":"2018","unstructured":"Mach\u00edo Castell\u00f3 M, Oses Lara M, Feliz Feliz C, et al. Is safinamide useful for atypical parkinsonian syndromes? Mov Disord. 2018;33(suppl 2):[abstract].","journal-title":"Mov Disord"},{"issue":"2","key":"e_1_3_4_25_1","article-title":"Is there a role for safinamide in atypical parkinsonian syndromes?","volume":"37","author":"Silva A","year":"2022","unstructured":"Silva A, Rodrigues M. Is there a role for safinamide in atypical parkinsonian syndromes? Mov Disord [Internet]. 2022;37(suppl 2):[abstract].","journal-title":"Mov Disord"},{"issue":"2","key":"e_1_3_4_26_1","article-title":"Is safinamide helpful in multiple system atrophy?","volume":"34","author":"Sim\u00f5es R","year":"2019","unstructured":"Sim\u00f5es R, Gon\u00e7alves A, Ferreira JJ. Is safinamide helpful in multiple system atrophy? Mov Disord [Internet]. 2019;34(suppl 2):[abstract].","journal-title":"Mov Disord"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100031863"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.61.3.259"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000008053"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/09727531231222700"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000291"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-9452(77)80040-3"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00249-0"},{"issue":"2","key":"e_1_3_4_34_1","article-title":"Establishing the first apomorphine treatment registry in Thailand: prospective data collection to inform optimal care of Parkinson\u2019s disease patients","volume":"34","author":"Bhidayasiri R","year":"2019","unstructured":"Bhidayasiri R, Phokaewvarangkul O, Boonpang K, et al. Establishing the first apomorphine treatment registry in Thailand: prospective data collection to inform optimal care of Parkinson\u2019s disease patients. Mov Disord. 2019;34(suppl 2):[abstract].","journal-title":"Mov Disord"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000183240.47960.f0"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.05.018"},{"issue":"2","key":"e_1_3_4_37_1","article-title":"Continuous dopaminergic treatment with levodopa\/carbidopa intestinal gel in multiple system atrophy: report of three patients","volume":"34","author":"Delalic S","year":"2019","unstructured":"Delalic S, Ibrulj S, Zupancic N, et al. Continuous dopaminergic treatment with levodopa\/carbidopa intestinal gel in multiple system atrophy: report of three patients. Mov Disord. 2019;34(suppl 2):[abstract].","journal-title":"Mov Disord"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-223504"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.98.4.0882"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.01.005"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurom.2024.09.126"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29573"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.11.1554"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.04.022"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/MRR.0000000000000455"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.09.026"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20211"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2024.100240"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1403.2011.00336.x"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.2022.763001"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.05.020"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26356"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2016.11.001"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006210"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103946"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08001-4"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1089\/brain.2014.0325"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.755352"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.03.24"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.09.001"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-024-01744-4"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25880"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107974"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/ner.12589"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12804"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2006.04.002"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28569"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6655-7"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-014-0249-7"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2023.10.028"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540340074015"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-019-00643-7"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23338"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00058-7"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.05.064"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309999"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70327-7"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-320846"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-011-0119-5"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2020.11.024"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25170"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25834"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-018-0529-8"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050479"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332733"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8375-x"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00169-7"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16061"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230173"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12249"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01025-2"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0425-3"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03030.x"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-004-0187-x"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2014.10.012"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-009-0522-3"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2022.0018"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2024.103216"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04225"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.6.951"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90230-M"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1574746"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-017-0867-5"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-024-01051-2"},{"key":"e_1_3_4_105_1","unstructured":"Study details | NCT05696717 | phase 3 efficacy and durability of Ampreloxetine for the treatment of symptomatic nOH in participants with multiple system atrophy | ClinicalTrials.Gov [Internet]. [cited 2025 Sep 21]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05696717?cond=Multiple%20System%20Atrophy&intr=Ampreloxetine&rank=1"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90737-7"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.11.994"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012868.pub2"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907123010202"},{"issue":"10","key":"e_1_3_4_110_1","doi-asserted-by":"crossref","first-page":"e006848","DOI":"10.1161\/JAHA.117.006848","article-title":"Fludrocortisone is associated with a higher risk of all\u2010cause hospitalizations compared with midodrine in patients with orthostatic hypotension","volume":"6","author":"Grijalva CG","year":"2025","unstructured":"Grijalva CG, Biaggioni I, Griffin MR, et al. Fludrocortisone is associated with a higher risk of all\u2010cause hospitalizations compared with midodrine in patients with orthostatic hypotension. J Am Heart Assoc [Internet]. 2025;6(10):e006848.","journal-title":"J Am Heart Assoc"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.9.1294"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.124.24050"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2024-003106"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.091355"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-6-1051"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2112809"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-12919-2"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816100-00006"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7339-2"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-015-0336-4"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.23.2710"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.04.011"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002078"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04116"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.105171"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V10135"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000199982.71858.11"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00377"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06617"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-022-01168-7"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22332"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-018-0550-y"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13307"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70119"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.02.036"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.02.025"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22645"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.06.023"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-003-0052-3"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.67.4.542"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100318"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.25291"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1838(99)00105-8"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.3.371"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41585-025-01076-W"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.03.027"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28854"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28852"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.120008"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1002\/MDC3.70355"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-021-10265-9"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00080"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181d8c1b7"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10276"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-014-1950-y"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10420"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.53"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120617"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21243"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0348-7"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-007-0020-7"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26918"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.03.003"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23168"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0390-x"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01543.x"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-014-1202-6"},{"key":"e_1_3_4_168_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118777251.ch14"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-018-0503-8"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2018.08.007"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2010.359"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-12-130"},{"key":"e_1_3_4_173_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.10268"},{"key":"e_1_3_4_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116891"},{"key":"e_1_3_4_175_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1207"},{"key":"e_1_3_4_176_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20898"},{"key":"e_1_3_4_177_1","doi-asserted-by":"publisher","DOI":"10.3389\/frsle.2023.1302021"},{"key":"e_1_3_4_178_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.677213"},{"key":"e_1_3_4_179_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-015-0279-9"},{"key":"e_1_3_4_180_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab257"},{"key":"e_1_3_4_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2019.10.004"},{"key":"e_1_3_4_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2017.10.006"},{"key":"e_1_3_4_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2025.106554"},{"key":"e_1_3_4_184_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.10424"},{"key":"e_1_3_4_185_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24909"},{"key":"e_1_3_4_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2021.07.011"},{"key":"e_1_3_4_187_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2012.08.010"},{"key":"e_1_3_4_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2015.05.005"},{"key":"e_1_3_4_189_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.11472"},{"key":"e_1_3_4_190_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-022-02739-3"},{"key":"e_1_3_4_191_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29993"},{"key":"e_1_3_4_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2004.10.002"},{"key":"e_1_3_4_193_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821ccd07"},{"key":"e_1_3_4_194_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008208"},{"key":"e_1_3_4_195_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-022-02607-0"},{"key":"e_1_3_4_196_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000725"},{"key":"e_1_3_4_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2017.12.008"},{"key":"e_1_3_4_198_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.5500"},{"key":"e_1_3_4_199_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7368"},{"key":"e_1_3_4_200_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003156"},{"key":"e_1_3_4_201_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-12969-6"},{"key":"e_1_3_4_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02824-5"},{"key":"e_1_3_4_203_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000137043.76383.A4"},{"key":"e_1_3_4_204_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27395"},{"key":"e_1_3_4_205_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2001.t01-1-00237.x"},{"key":"e_1_3_4_206_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-206372"},{"key":"e_1_3_4_207_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15347"},{"key":"e_1_3_4_208_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.2.256"},{"key":"e_1_3_4_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.01.008"},{"key":"e_1_3_4_210_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.04.016"},{"key":"e_1_3_4_211_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.4.649"},{"key":"e_1_3_4_212_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.2272"},{"key":"e_1_3_4_213_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-206156"},{"key":"e_1_3_4_214_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2007.04.009"},{"key":"e_1_3_4_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.03.025"},{"key":"e_1_3_4_216_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2016.01.017"},{"key":"e_1_3_4_217_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28218"},{"key":"e_1_3_4_218_1","unstructured":"Study details | NCT06568237 | a study to test if TEV-56286 is effective in relieving multiple system atrophy (MSA): a safety and efficacy study. ClinicalTrials.gov [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06568237"},{"key":"e_1_3_4_219_1","unstructured":"Study details | NCT05109091 | study of ATH434 in participants with multiple system atrophy | ClinicalTrials.Gov [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05109091"},{"issue":"34","key":"e_1_3_4_220_1","first-page":"S15","article-title":"Poster S224 - ATH434 slows disease progression in a phase 2 study in multiple system atrophy - 150th annual meeting American neurological association","volume":"98","author":"Claassen D","year":"2025","unstructured":"Claassen D, Wong C, Trujillo P, et al. Poster S224 - ATH434 slows disease progression in a phase 2 study in multiple system atrophy - 150th annual meeting American neurological association. Ann Neurol [Internet]. 2025;98(Suppl 34):S15.","journal-title":"Ann Neurol"},{"key":"e_1_3_4_221_1","unstructured":"Study details | NCT05526391 | a study of TAK-341 in treatment of multiple system atrophy. ClinicalTrials.gov [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT05526391"},{"key":"e_1_3_4_222_1","unstructured":"Study details | NCT05104476 | a study of Lu AF82422 in participants with multiple system atrophy. ClinicalTrials.gov [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT05104476"},{"key":"e_1_3_4_223_1","unstructured":"Study details | NCT06706622 | a trial of Lu AF82422 in participants with multiple system atrophy (MSA). ClinicalTrials.gov [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06706622"},{"key":"e_1_3_4_224_1","unstructured":"Study details | NCT04165486 | study to evaluate the safety tolerability and pharmacokinetics of ION464 administered to adults with multiple system atrophy (HORIZON) | ClinicalTrials.Gov [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04165486"},{"key":"e_1_3_4_225_1","unstructured":"Study details | NCT06848231 | a phase 2 study of YA-101 in patients with multiple system atrophy. ClinicalTrials.gov [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT06848231"},{"key":"e_1_3_4_226_1","unstructured":"Study details | NCT06868628 | a phase 2a study of Foralumab nasal in patients with multiple system atrophy (MSA). ClinicalTrials.gov [Internet]. [cited 2025 Sep 28]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06868628"},{"key":"e_1_3_4_227_1","unstructured":"Study details | NCT03952806 | study of BHV-3241 in participants with multiple system atrophy (M-STAR). ClinicalTrials.gov [Internet]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03952806"},{"key":"e_1_3_4_228_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007720"},{"key":"e_1_3_4_229_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101920"},{"key":"e_1_3_4_230_1","unstructured":"Study Details | NCT04680065 | GDNF Gene Therapy for Multiple System Atrophy. ClinicalTrials.gov Available from: https:\/\/clinicaltrials.gov\/study\/NCT04680065"},{"key":"e_1_3_4_231_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.70004"},{"key":"e_1_3_4_232_1","unstructured":"Our Pipeline. Takeda Pharmaceuticals. [cited 2025 Dec 12]. Available from: https:\/\/www.takeda.com\/science\/pipeline\/"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2025.2605711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:14:17Z","timestamp":1772716457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2025.2605711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":231,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/14737175.2025.2605711"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2025.2605711","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}